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Approximately 200 000 new cases of renal cell cancer (RCC) are diagnosed all over the world every year, constituting the third most common genitourinary cancer, following bladder and prostate cancers (1) . Indeed, RCC is one of the most lethal urological tumors; it is believed that 40% of RCC-diagnosed patients will die as a result of such disease, approximately 100 000 deaths per year all over the world (2) . Moreover, the annual incidence of RCC has increased 2.5%, which is attributed at least in part to the widespread use of non-specific abdominal imaging (3, 4) . The current RCC series in literature shows that 60-70% of the patients are asymptomatic at the diagnosis (5) . This change in the incidental presentation of renal mass doubled the prevalence of the localized disease from 1975 to 1995 (6, 7) . Paradoxically, despite diagnosis and early treatment, there has been an increase in the overall and diseasespecific mortality rates in the last twenty years, according to SEER (Surveillance, Epidemiology, and End Results Program) database (8) . In spite of INTRODUCTION that, there are groups of patients with small, nonaggressive tumors which can be dealt with with conservative treatment or with only surveillance.
In Brazil there have been no data collected addressing the epidemiological profile of RCC. Therefore, the current incidence of incidental and symptomatic tumors and their respective staging and treatment is not known. The aim of this study was to evaluate the symptoms at diagnosis (incidental and symptomatic), the size of the tumors, the type of surgery performed (radical and conservative), the TNM stage and the anatomopathological characteristics of the sporadic RCC who are treated in two tertiary hospitals, one public and another private, in our country.
MATERIALS AND METHODS
We performed a retrospective study in which we reviewed prospectively collected data from 183 patients who underwent surgical treatment for RCC between July 2003 and December 2007 in two tertiary hospitals in Brazil. Ninety-three patients were treated at a public hospital (Hospital das Clínicas da Faculdade de Medicina de Sao Paulo), and ninety patients at a private hospital (Sociedade Beneficente de Senhoras Hospital Sírio-Libanês-Sao Paulo).
The data evaluated included the clinical presentation at the diagnosis (incidental or symptomatic), the type of surgery performed (conservative or radical) and anatomo-pathological characteristics (histological type, presence of sarcomatous differentiation, Furhman's nuclear grading system, presence of microvascular invasion, tumor size and TNM stage) 14. These characteristics were comparatively analyzed between the public and private hospital patients.
Postoperative follow-up included abdominal computed tomography and/or ultrasonography and hematological exams every four months during the two initial years, and every six months from the third to the fifth year. When the last consultation had taken place more than three months earlier, there was a telephone confirmation of the patient's current health condition.
For the statistical analysis the student's ttest and chi-square test were used. Results with pvalues inferior to 5% (p < 0.05) were considered significant. Both institutions' review boards approved the study prior to accruing the patients, and informed consent was signed by all participants.
RESULTS
The median age was equivalent in both groups (56 vs. 60 years; p = 0.204). There was predominance of male patients at the private hospital compared to the public hospital (90% vs. 61. 3%; p < 0.001) ( Table-1 ).
The diagnosis of the symptomatic tumors at the public hospital is 47.3% vs. 33.3% (Table-2) . At the private hospital, there was a higher rate of patients with hematuria, whereas the public hospital showed a higher rate of patients presenting the classical triad (hematuria/pain/palpable mass). It is also worth noting that more patients presented metastatic disease at diagnosis at the public hospital when compared to the private hospital (Table-3 ). The proportion of conservative surgery practically doubles at the private hospital (p = 0.008) ( Table-2 ). The median tumor size was significantly different in both hospitals (Table-4): the median size was smaller than 4 cm at the private hospital and larger than 6 cm at the public hospital (p < 0.001). Another remarkable finding is that 58% of the tumors at the private hospital are smaller than 4 cm against only 28% at the public hospital (p < 0.001).
The pathological characteristics of the RCC in both hospitals are represented in Table- 
DISCUSSION
There were marked differences in the clinical presentation, type of surgery performed and histological findings of the RCC treated at public and private hospitals in Brazil. The median size of RCC detected at the private hospital was 2.4 cm, smaller than those detected at the public hospital. Nephron-sparing surgery was performed in half of the patients at the public hospital when compared to the private one. Furthermore, whereas approximately 60% of the patients operated on at the private hospital had tumors smaller than 4 cm, more than 70% of the public hospital patients presented tumor larger than 4 cm. pT1 RCC tumors occurred in 72% of the private hospital patients and in only 40% of the public hospital patients. Therefore, the fact that the public hospital is an academic teaching environment and the private is essentially a private practice probably did not play such an important role in determining the surgical approach in our study as did the tumor stage.
Differences in RCC histology between the groups reported in the present study may be associated with the disparate median tumor sizes. Patients with small renal masses (SRM) were probably less frequently referred to the public hospital, since it is a tertiary referral institution.
Radical nephrectomy was a rather common option in the public hospital, comprising 75% of renal surgeries, whereas at the private hospital, radical nephrectomy was performed in 57% of the cases. Long-term functional results for the patients who have undergone radical and conservative nephrectomy are very different . Lau et al. (9) have reported that the progression towards renal insufficiency (creatinine > 2 mg/dL) ten years after the renal surgery occurred in 22.4% of the patients who were submitted to radical nephrectomy versus 11.6% after partial nephrectomy.
RCC is a classically aggressive tumor; in clinical series from developed countries, onethird of the patients present metastasis at the diagnosis (10). Indeed, more than 40% of the RCC patients die due to that disease (11) . The risk of death caused by RCC may be higher in developing countries like Brazil, especially in public hospitals. In our study, symptomatic and metastatic tumors comprised 47% and 15%, respectively, of the tumors treated at public hospitals and 33% and 4% of the tumors treated at private hospitals. In the United States, 25-30% of the patients initially present with metastatic RCC (12) .
Today, more than 60% of RCC cases are incidentally detected in developed countries. (8, (12) (13) (14) (15) (16) . Nevertheless, in the present study, in- cidental diagnosis occurred in 67% of Brazilian private hospital patients and 53% of public hospital patients. Since the Brazilian public health system is based on universal coverage for approximately 203 million people, of which 68% have no private health insurance, medical visits and tests are often delayed due to long waiting lists (17) .
The 2002 TNM presented a new proposal for the RCC stage, especially in T1 tumors (smaller than 7 cm, restricted to the kidney) (14) . RCC stage T1 includes tumors with different outcomes. For instance, the likelihood of death within ten years for a patient with a 5-cm, low-degree RCC is less than 3%; however, a high-degree 5-7 cm RCC has a 40% likelihood of death in ten years (18) . In Brazilian private and public hospitals approximately 72% and 41% of the patients presented stage pT1 tumors, respectively. Considering that life expectancy for T1 tumors is much higher, we can expect a higher RCC mortality at the Brazilian public institutions than at private hospital, a rather peculiar characteristic for our country. At the public hospital the classical triad (hematuria/ pain/palpable mass), identified in 28% of the public hospital patients and 8% of the private hospital patients, respectively -can still be found.
An important limitation is that both are distinct pathology services and the surgeon's experience at the private hospital is higher. The data from public hospitals on diagnosis of metastatic disease are probably underestimated, and it is possible that data are actually higher.
Currently, renal masses are detected incidentally, with smaller sizes constituting the ideal cases for conservative surgery (19, 20) . However, recent series from developed countries showed that conservative kidney surgery has been underutilized; only 9.6% of the surgeries carried out due to RCC are conservative (21) . In this context, our study showed that nephron-sparing surgery was carried out in 43% and 24% of private and public hospital individuals, respectively. Although not broadly representative, these two particular hospitals may indirectly reflect the patterns of care in the private and public health systems in Brazil. Nonetheless, an external validation of these findings is needed to confirm this discrepancy.
CONCLUSIONS
Patients with RCC operated on at a tertiary public hospital in Brazil showed a more technically advanced histopathological evaluation than those treated at a private institution, reflecting the different standards of treatment that patients may undergo according to their socioeconomic level.
